A 9 year old girl vitally stable and active but she is having little puffy face since 3 days. What is the cause and treatment
Reading File
Finding Sources
Finding Sources
Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Searching PubMed
nephrotic syndrome children treatment
Reading File
Reading Article
PMID: 40254362
Reading File
Reading File
Loading Image
Here is a thorough clinical answer based on authoritative sources:
Diagnosis: Nephrotic Syndrome - Most Likely Minimal Change Disease (MCD)
A 9-year-old girl presenting with a puffy face (periorbital/facial edema) for 3 days while remaining vitally stable and active is a classic presentation of Nephrotic Syndrome, with Minimal Change Disease as the most likely underlying cause at this age.
Why This Diagnosis?
Classic Nephrotic Syndrome Features
The "puffy face" is the first and most noticeable sign - periorbital edema is typically worse in the morning (as fluid redistributes from gravity-dependent areas during sleep). Parents often mistake it for allergy or insect bite initially.
The full tetrad of Nephrotic Syndrome:
| Feature | Mechanism |
|---|---|
| Massive proteinuria (>3.5 g/day in adults, >40 mg/m²/hr in children) | Damaged glomerular filtration barrier leaks protein |
| Hypoalbuminemia (<2.5 g/dL) | Urinary protein loss exceeds hepatic synthesis |
| Generalized edema (starting as periorbital puffiness) | Low oncotic pressure + sodium/water retention |
| Hyperlipidemia + Lipiduria | Compensatory hepatic lipoprotein synthesis |
Why Minimal Change Disease?
- MCD is the most common cause of nephrotic syndrome in children, especially between ages 1-7 years (though extends to school age)
- The child is vitally stable and active - renal function is usually preserved in MCD
- The glomeruli appear histologically normal on light microscopy (hence "minimal change")
- The only abnormality is podocyte foot process effacement visible on electron microscopy
Pathogenesis
The leading hypothesis involves circulating factors (likely T-cell derived) that injure podocytes, causing foot process effacement and disruption of the slit diaphragm. This results in:
- Podocyte injury → slit diaphragm disruption
- Selective proteinuria (mainly albumin - smaller plasma proteins)
- Hypoalbuminemia → reduced plasma oncotic pressure
- Fluid shifts to interstitium → edema (starts periorbitally/face, then ascites, scrotal/labial edema, pleural effusion)
- Compensatory RAAS activation → sodium and water retention (worsening edema)
- Hepatic lipoprotein overproduction → hyperlipidemia
An immune mechanism is strongly suspected because the disease responds dramatically to steroids. - Robbins & Kumar Basic Pathology, p. 503
Workup to Confirm
| Investigation | Expected Finding |
|---|---|
| Urine dipstick | 3+ or 4+ protein (massive proteinuria) |
| Spot urine protein:creatinine ratio | >200 mg/mmol (>2 in adults) |
| 24-hr urine protein | >40 mg/m²/hr in children |
| Serum albumin | Low (<2.5 g/dL) |
| Serum cholesterol/triglycerides | Elevated |
| Serum creatinine/urea | Usually normal in MCD |
| CBC | May show hemoconcentration |
| Urine microscopy | Oval fat bodies, no RBC casts (nephrotic pattern) |
| Complement (C3, C4) | Normal in MCD |
| Renal biopsy | Usually NOT needed in a child with typical presentation; reserved for atypical cases |
Note: In a child aged 1-12 years with typical nephrotic syndrome and no atypical features (hypertension, hematuria, renal impairment, hypocomplementemia), biopsy is usually deferred and empiric steroid therapy is started - as >90% will have MCD and respond.
Treatment
1. First-Line: Oral Corticosteroids (Prednisolone)
The KDIGO 2025 guideline (the most current international standard) confirms corticosteroids as first-line therapy:
- Prednisolone: 60 mg/m²/day (or 2 mg/kg/day, max 60 mg) as a single morning dose for 4-6 weeks
- Then 40 mg/m² on alternate days for 4-6 weeks, then taper
- >90% of children with MCD achieve complete remission (proteinuria clears) within 2-4 weeks
The KDIGO 2025 Guideline now provides specific algorithms for when to perform kidney biopsy or genetic testing, and which steroid-sparing agent to choose if the child relapses.
2. Supportive Measures
| Measure | Details |
|---|---|
| Salt restriction | Low-sodium diet to reduce edema |
| Fluid restriction | If severe edema |
| Diuretics | Use cautiously (frusemide) only if significant edema/ascites - risk of hypovolemia |
| Albumin infusion | Only for severe symptomatic hypoalbuminemia + hypovolemia |
| Penicillin prophylaxis | Against Streptococcal infections - nephrotic children are at risk of peritonitis |
| Pneumococcal vaccine | Before starting steroids if possible |
3. Relapsing Disease
- Relapses occur in >2/3 of initial responders
- Frequently relapsing / Steroid-dependent: Add steroid-sparing agents:
- Levamisole (low-cost, well tolerated)
- Oral cyclophosphamide (for remission consolidation)
- Mycophenolate mofetil (MMF)
- Calcineurin inhibitors (tacrolimus, cyclosporine)
- Rituximab (for difficult steroid-dependent cases)
4. Biopsy Indications in This Age Group
Reserve renal biopsy for:
- Age <1 year or onset in infancy (congenital NS)
- Persistent hematuria / low complement
- Hypertension at presentation
- Renal impairment at presentation
- No response to steroids after 8 weeks (steroid-resistant NS)
Prognosis
- Excellent in MCD - does not cause kidney failure
- Most children enter remission with steroids and outgrow the disease by adolescence
- Significant steroid side effects (growth impairment, weight gain, hypertension, cataracts) are the main long-term concern with relapsing courses
Other Causes to Consider (if Atypical)
| Condition | Clue |
|---|---|
| FSGS | Steroid-resistant, hematuria, older children/adults |
| Post-streptococcal GN | Hematuria, hypertension, low C3, history of throat/skin infection |
| Allergic reaction | Acute onset, urticaria, exposure history |
| Hypothyroidism | Myxedema - but the child would not be vitally active |
| SLE nephritis | Older girls, rash, arthralgia, low complement |
Given this child's age, activity, vital stability, and 3-day course of facial puffiness with no other features described, Nephrotic Syndrome from MCD remains the overwhelming working diagnosis pending urine protein testing.
Sources: Robbins & Kumar Basic Pathology, p. 503-505; Tietz Textbook of Laboratory Medicine 7th Ed.; KDIGO 2025 Clinical Practice Guideline for Nephrotic Syndrome in Children [PMID: 40254362]
This is a shared conversation. Sign in to Orris to start your own chat.